Price target
14.530.000.00%
The 2 analysts offering 1 year price forecasts for 1S90 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 3 analysts giving stock ratings to 1S90 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
1S90 EPS for the last quarter is −1.93 EUR despite the estimation of −2.11 EUR. In the next quarter EPS is expected to reach 0.38 EUR. Track more of Seres Therapeutics Inc financials and stay on top of what is up with the company.
In the next quarter Seres Therapeutics Inc revenue is expected to reach 6.69 M EUR. Check out Seres Therapeutics Inc revenue and earnings and make informed decisions.
According to analysts, 1S90 price target is 14.53 EUR with a max estimate of 17.09 EUR and a min estimate of 11.96 EUR. Check if this forecast comes true in a year, meanwhile watch Seres Therapeutics Inc stock price chart and keep track of the current situation with 1S90 news and stock market news.